Wun, T., Knupp, C. L., McMahon, L. E., Strouse, J. J., Zhou, C., Heath, L. E., … Riesmeyer, J. S. (2011). Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease. In BLOOD (Vol. 118, pp. 931–932). San Diego, CA: AMER SOC HEMATOLOGY.

Wun, Ted, Charles L. Knupp, Lillian E. McMahon, John J. Strouse, Chunmei Zhou, Lori E. Heath, Chuke E. Nwachuku, Joseph A. Jakubowski, Kenneth J. Winters, and Jeffrey S. Riesmeyer. “Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease.” In BLOOD, 118:931–32. AMER SOC HEMATOLOGY, 2011.

Wun T, Knupp CL, McMahon LE, Strouse JJ, Zhou C, Heath LE, et al. Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 931–2.

Wun, Ted, et al. “Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 931–32.

Wun T, Knupp CL, McMahon LE, Strouse JJ, Zhou C, Heath LE, Nwachuku CE, Jakubowski JA, Winters KJ, Riesmeyer JS. Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 931–932.